Category: Business news
-
PBC Startup Crystal Sonic receives SBIR grant from NASA
Phoenix-based Crystal Sonic recently announced it was awarded a Phase II SBIR grant from NASA to advance its materials processing technology, which reduces waste and costs in the semiconductor industry.
-
Skysong Innovations to launch office hours at 850 PBC
SkySong Innovations will host office hours at 850 PBC in the ASU Edson E+I suite to foster a culture of entrepreneurship on the Phoenix Bioscience Core.
-
Three emerging growth companies move to Connect Labs by Wexford PHX
ExoDigm, Crystal Sonic, Medi Life join Connect Labs by Wexford Science + Technology on the Phoenix Bioscience Core.
-
Calviri: Canines Are Leading the Fight Against Human Cance
Calviri Inc. CEO Dr. Stephen Johnston recently wrote an article in Pharmacy Times discussing how important the relationship is between canines and humans in the fight against cancer. Calviri, an ASU spinout located on the Phoenix Bioscience Core. The company is working on a cancer vaccine that is currently part of the largest preventative cancer…
-
Phoenix a “key emerging life science talent cluster” according to national report
The Phoenix MSA is a top emerging life science talent clusters in the nation, according to a new report from CBRE.
-
Ivy Brain Tumor Center appoints new chief medical officer, focused on clinical trial program
The Ivy Brain Tumor Center and Barrow Neurological Institute are pleased to announce the addition of Yoshie Umemura, MD, as the new Chief Medical Officer of the Ivy Brain Tumor Center and Division Chief of Neuro-Oncology and the William and Joan Shapiro Chair of Neuro-Oncology at Barrow Neurological Institute.
-
Xcellerant Ventures, Flinn Foundation partner to grow Arizona bioscience and health care sectors
Xcellerant Ventures and the Flinn Foundation announced May 22 that the Flinn Foundation would be joining Xcellerant’s Venture Capital Fund I as a limited partner to support early and seed-stage startups in the HealthTech and MedTech space in Arizona.
-
Calviri Scientists Find New Class of Biomarkers for Predicting Treatment Response in Cancer Patients
Researchers at Calviri have discovered a new biomarker in lung cancer patients that could better predict treatment response.
-
Wexford Science + Technology’s 850 PBC receives LEED Gold status
850 PBC, a 227,000 square foot lab and office developed by Wexford Science + Technology, received LEED Gold certifications by the U.S. Green Building Council for both the Core and Shell and the Interiors of the building.
-
Arizona PBS features Translational Sciences CEO and Dean of College of Medicine – Phoenix Dr. Guy Reed
Translational Sciences CEO and dean of the University of Arizona College of Medicine – Phoenix appeared on Arizona PBS to discuss TS23.
